Breaking Boundaries for Future Treatments

July 24, 2024 by Aldevron

Emerging Trends in Cell and Gene Therapy

What do you get when you gather cell and gene therapy experts from around the world in Vancouver, British Columbia? In the case of the ISCT 2024 Annual Meeting, you find a vibrant melting pot of innovation, excitement, and cutting-edge science. With multiple standout moments. We learned about the latest breakthroughs in the field, which offered potentially game-changing insights that could provide new approaches for therapeutic development.

Revolutionizing Treatment with Diverse Cell Types
The conference buzzed with talks about the revolutionary potential of various cell types, including induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs). Imagine a world where these cells can be harnessed to cure diseases previously thought untreatable. The versatility and therapeutic promise of these cells are lighting up new paths in medical research.

Non-viral Delivery Methods: A Safer, Smarter Approach
Non-viral delivery methods, especially combined with Nanoplasmid^TM technology, were a highlight of the event. Researchers from several organizations presented impressive data on using Nanoplasmid as an HDR template in CRISPR-mediated ex vivo cell therapies. This method not only boosts safety and efficiency but also sidesteps the risks associated with viral vectors.

Electroporation: Precision at Its Best
Electroporation technology was another hot topic, praised for its precision in gene editing and delivery. By bypassing viral vectors, this method offers a less expensive, safer way to modify cells. The future of cell therapy looks brighter with these advancements, paving the way for more effective treatments.

Power of Partnerships: Academic and Industry Collaborations
ISCT 2024 underscored a powerful message: collaboration is key. When academia and industry join forces, magic can happen. For example, Vimal Keerthi from Stanford Medicine’s Laboratory for Cell and Gene Medicine showcased groundbreaking results using Nanoplasmid in CRISPR-mediated CAR-T cell therapy. This collaboration highlights how blending academic innovation with industry support can lead to life-changing advancements.

Navigating the Regulatory Maze: From Lab to Clinic
Understanding the regulatory landscape is crucial for translating research into real-world treatments. Intellia Therapeutics’ Dr. Laura Sepp-Lorenzino shared thrilling clinical data on phase 3 CRISPR-Cas9 in vivo studies. She highlighted the hurdles and triumphs in achieving targeted liver delivery and improving gRNA accuracy. Her insights illuminate the path forward for future therapies.

Tackling the Tough Stuff: Challenges in Gene Editing

• Precision and Safety: The Twin Pillars
  Gene editing’s biggest hurdles—precision and safety—were tackled head-on. Innovations in guide RNA (gRNA) technology are pushing the boundaries of accuracy, while new methods to transiently express Cas9 are making treatments safer. The journey towards perfecting gene editing continues, but the strides made are nothing short of impressive.

• Novel Delivery Innovations: “More shots on goals”
  Dr. Bruce Levine from the University of Pennsylvania captivated the audience with his novel delivery methods for mRNA/LNP therapeutics. He introduced an innovative approach using conjugate antibodies to redirect lipid nanoparticles (LNPs) from the liver to the spleen. This technique targets conditions requiring only transient gene expression, making it ideal for therapies that don’t need permanent genetic modifications.

Early animal studies showed exceptional results in targeted delivery, marking a significant breakthrough in the field. Dr. Levine’s work is paving the way for more precise and effective delivery mechanisms, which could revolutionize how treatments are administered and improve patient outcomes.

The Takeaway
The ISCT 2024 Annual Meeting in Vancouver wasn’t just another conference; it was a glimpse into the future of cell and gene therapy and what we as an industry can accomplish. From groundbreaking research and technological innovations to practical advice for better engagement, the event was a treasure trove of knowledge and inspiration.

• Learn more about Aldevron’s custom manufacturing services
• Get more information about Nanoplasmids
• Have questions on this topic? Contact Us
• Have an idea for a topic? Let us know!

Subscribe to our blog